Phosphatidylinositol 3-kinase (PI3K) inhibitors: a recent update on inhibitor design and clinical trials (2016 –2020)

.

Source: Expert Opinion on Therapeutic Patents - May 16, 2021 Category: Drugs & Pharmacology Authors: Dima A. Sabbah Rima Hajjo Sanaa K. Bardaweel Haizhen A. Zhong Source Type: research